Pulse oximetry as a screening tool for congenital heart diseases
DOI:
https://doi.org/10.24265/horizmed.2025.v25n1.02Keywords:
Congenital Abnormalities , Heart Defects, Congenital , Neonatal Screening , Oxygen Saturation, OximetryAbstract
Objective: To report the results of pulse oximetry screening for congenital heart diseases in healthy newborns during the transitional period between birth and discharge. Those with positive screening results were referred for echocardiographic evaluation aimed at a specific diagnosis. Materials and methods: A retrospective, descriptive, observational and cross-sectional study. Data were obtained from screening 4,897 newborns who were admitted to the nursery of the Obstetrics and Gynecology Unit at Hospital Universitario de Guayaquil, within the first 24 hours of birth, all diagnosed as healthy newborns. As part of the protocol, cardiac screening was performed on all newborns at admission and discharge. Newborns with saturation levels below 95 % on pulse oximetry underwent consecutive measurements at one-hour intervals, with a total of three readings. Additionally, those with more than a 3 % difference in saturation between preductal and postductal readings were also monitored. Newborns with positive screening results underwent transthoracic echocardiography to evaluate for heart defects. Results: Among the 4,897 newborns, 626 (12.8 %) had a positive neonatal cardiac screening, out of which 497 (79.4 %) were diagnosed with some form of structural heart defect. Persistent ductus arteriosus was the most frequent f inding, with 127 cases (25.55 %). Critical malformations such as aortic aneurysms and coarctation of the aorta were reported in 0.8 % and 1.6 %, respectively. Conclusions: Screening for congenital heart diseases using pulse oximetry during the transitional period prior to discharge is essential for the early detection of congenital heart diseases in healthy newborns.
Downloads
References
Meller CH, Grinenco S, Aiello H, Córdoba A, Sáenz-Tejeira MM, Marantz P, et al. Congenital heart disease, prenatal diagnosis and management. Arch Argent Pediatr [Internet]. 2020;118(2):149-61.
Armas López M, Sierra RE, Rodríguez Collado Y, Elias Armas KS. Morbilidad y mortalidad neonatal por cardiopatías congénitas. Rev Cubana Pediatr [Internet]. 2019;91(1):661.
Ministerio de Salud Pública. Gacetas Epidemiológicas: Gaceta General 2020 [Internet]. Ecuador: Ministerio de Salud Pública; 2020. Disponible en: https://www.salud.gob.ec/gacetas-epidemiologicasgaceta-general-2020/.
Ramírez-Escobar M, Betancurt-Serrano J, Ramírez-Cheyne J, Torres-Muñoz J, Madrid-Pinilla AJ. La pulsioximetría como herramienta para la tamización de cardiopatías congénitas críticas. Una revisión narrativa Revista Colomb Cardiología [Internet]. 2019;26(1):33-42.
Berlanga-Bolado O, Rivera-Vásquez P, Martínez Padrón HY. Sensitivity and specificity of pulse oximetry to detect congenital heart disease in newborns. Horiz Sanitario [Internet]. 2023;22(2):271-78.
Jiménez Carvajal MG, López Pérez D, Fernández Luna CP. Relevancia de la detección de cardiopatías congénitas complejas mediante cribado con oximetría de pulso en recién nacidos aparentemente sanos en los establecimientos de salud. Arch Cardiol Méx [Internet]. 2018;88(4):298-305.
Flórez-Muñoz Sandra L, Rubiano-Pedroza José A, Molina-Medina Clara N, Lozada-Muñoz Adriana, Rocha-Pacheco Lila M. Tamizaje con oximetría de pulso en el diagnóstico de cardiopatías congénitas críticas en recién nacidos. Revista Colomb Cardiología [Internet]. 2021(6):583-89.
Huang Y, Zhong S, Zhang X, Kong L, Wu W, Yue S, et al. Large scale application of pulse oximeter and auscultation in screening of neonatal congenital heart disease. BMC Pediatr [Internet]. 2022;22(483).
Suárez-Ayala D, Morcillo-Bastidas K, Vallejo-Mondragón EL, Valencia-Salazar A, Madrid-Pinilla A. Conocimiento y aplicación del tamizaje neonatal de cardiopatías congénitas críticas mediante el uso de oximetría de pulso. Revista Colomb Cardiología [Internet]. 2016;23(6):553-59.
Cullen PJ, Guzmán CB. Tamiz de Cardiopatías congénitas Críticas. Recomendaciones Actuales. Acta Med Grupo Ángeles [Internet]. 2014;12(1)24-9.
De Rubens Figueroa J, Mier Martínez M, Jiménez Carvajal MG, García Aguilar H. Tamizaje neonatal cardiaco en México, una herramienta para el diagnóstico temprano de cardiopatías críticas. Gac Med Méx [Internet]. 2022;158(2):67-71.
Riede F, Worner C, Dahnert I, Mockel A, Kostelka M, Schneider P. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine—results from a prospective multicenter study. Eur J Pediatr [Internet]. 2010;169(8):975-81. Horiz Med (Lima) 2025; 25(1): e3068
Plana MN, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer AK. Pulse oximetry screening for critical congenital heart defects. Cochrane Database Syst Rev [Internet]. 2018;3:CD011912.
Cárdenas L, Enríquez G, Haecker S. Recién nacido portador de cardiopatía congénita compleja. Análisis de riesgo, toma de decisiones y nuevas posibilidades terapéuticas. Rev Med Clin Las Condes [Internet]. 2016;27(4):476-84.
Copado Mendoza DY, Martínez-Acevedo, S. Importancia del diagnóstico prenatal de las cardiopatías congénitas. Perinatol Reprod Hum [Internet]. 2018;32(3):127-30.
Janjua D, Singh J, Agrawal A. Pulse oximetry as a screening test for congenital heart disease in newborns. J Mother Child [Internet]. 2022;26(1):1-9.
Singh Y, Chen SE. Impact of pulse oximetry screening to detect congenital heart defects: 5 years’ experience in a UK regional neonatal unit. Eur J Pediatr [Internet]. 2022;181(2):813-21.
Martínez I, Buendía F, Pijuán T, Abelleira C, Sánchez I, Bautista V. Selección de lo mejor del año 2018 en cardiopatías congénitas. CardioClinics [Internet]. 2018;54(1):23-9.
Peña R, Corona C, Medina M, Garrido L, Gutierrez C, Mier M. Presentación y manejo de las cardiopatías congénitas en el primer año de edad. Arch Cardiol Méx [Internet]. 2021;91(3):337-46.
Quiroz Conforme JF, Regalado Muñiz LS, Quiroz Conforme NV, Mendoza Gutiérrez AJ. Causas y consecuencias de cardiopatías congénitas en recién nacido. RECIAMUC [Internet]. 2021;5(2):131-39.
Giraldo-Grueso M, Zarante I, Mejía-Grueso A, Gracia G. Factors for congenital heart disease: a case control stury. Rev Colomb Cardiología [Internet]. 2020;27(4):324-9.
Herrera Morban DA, Colomé-Hidalgo M, Méndez R, Torres Z, Jiménez S, Alcántara Tiburcio T, et al. Epidemiología de cardiopatías congénitas en un hospital de tercer nivel, Santo Domingo Norte, República Dominicana. Cienc y Salud [Internet]. 2020;4(2)37-44.
Barreto T. Pulse oximetry screening for critical congenital heart defects in newborns. Am Fam Physician [Internet]. 2019;99(7):421-2.
Mohammad N, Haikh S, Memon S, Das H. Spectrum of heart disease in children under 5 years of age at Liaquat University Hospital, Hyderabad, Pakistan. Indian Heart J [Internet]. 2014;66(1):145-9.
Méndez-Duran L, Echeverría-Consuegra R, Pérez O, Barbosa V, Contreras L, Cañón K. Prevalencia de cardiopatías congénitas diagnosticadas o tratadas por cateterismo cardiaco en pediatría. Rev Colomb Cardiología [Internet]. 2021;28(2):146-52.
Peña-Juarez R, Chávez-Saenz JA, García-Canales A, Medina-Andrade MA, Martínez-González MT, Gutiérrez-Cobián L, et al. Comparación de Oxímetros para detección de cardiopatías congénitas críticas. Arch Cardio Mex [Internet]. 2019;89(2):172-80.
Narayen IC, Te Pas AB, Blom NA, Van den Akker-van Marle ME. Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge. Eur J Pediatr [Internet]. 2019;178(1):97-103. 28. Wong KK, Fournier A, Fruitman DS, Graves L, Human DG, Narvey M, et al. Canadian cardiovascular Society/Canadian pediatric cardiology association position statement on pulse oximetry screening in newborns to enhance detection of critical congenital heart disease. Can J Cardiol [Internet]. 2017;33(2):199-208.
Abdala D, Di Cicco V. Diagnóstico prenatal de cardiopatías congénitas. Salud mil [Internet]. 2020;39(1):14-9.
González-Andrade F, Echeverría D, López V, Arellano M. Is pulse oximetry helpful for the early detection of critical congenital heart disease at high altitude? Congenit Heart Dis [Internet]. 2018;13(6):911-18.
Published
How to Cite
Issue
Section
License
Copyright (c) 1970 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).